A NuGenia Logics publication · Free to read

Pilot Trial of Melatonin for Sleep Management After Pediatric TBI

Sleep disturbances are common in pediatric survivors of traumatic brain injury (TBI), affecting over 50% of these individuals and potentially leading to worse cognitive and psychosocial outcomes. This study aimed to assess the feasibility and acceptability of an early intervention using melatonin and sleep education for children aged 6 to 18 years who have experienced TBI.

What this study does not show

While the study suggests that melatonin may reduce sleep disturbances, it was not powered to demonstrate effectiveness conclusively, and the results should be interpreted with caution.

Evidence scorecard

  • Analytic validity: established
  • Clinical validity: established
  • Clinical utility: partial

The evidence class for this study is human_rct, indicating that the findings are based on a randomized controlled trial involving human participants.

Sponsored
Article slot — 728×90

Evidence classes are taken from source metadata — publication type and trial registration — never from opinion. How we classify · Corrections